Research Matters in West Virginia
The West Virginia Research and Innovation Forum led by Shepherd University and Research!America was featured in a West Virginia Public Broadcasting segment which included remarks from Research!America President and CEO, Mary Woolley and state survey data.
A Herald-Mail article included comments from Research!America board member Mary Hendrix, Ph.D., president of Shepherd University, about the importance of stronger investments in research for the state’s workforce and population health. Articles about the forum were also included in Becker’s Hospital Review, The Martinsburg (W.V.) Journal, and WEPM-AM.
Research!America’s Chair The Hon. Michael N. Castle, described why scientists should engage lawmakers to support research funding and combat misinformation in Neuroscience Quarterly: “To stimulate a meaningful and productive public dialogue about science, researchers and advocates must be a part of the national conversation around “lightning rod” and noncontroversial science issues alike.”
Woolley penned a letter-to-the-editor that was published in the Pittsburgh Post-Gazette about finding a solution to the opioid epidemic. “We urge Congress to provide additional resources for research. It’s time for new ideas, the kind that come from putting innovative minds to work.”
Research!America board member Georges Benjamin, M.D., executive director, American Public Health Association wrote a guest commentary for Modern Healthcare about reducing the risk of gun violence with a comprehensive public health approach.
In a MedPage Today article about a Lancet study which showed the increase in the number of obese children worldwide, Research!America board member Nancy Brown, CEO, American Heart Association, commented on the importance of implementing evidence-based strategies and policies to curb childhood obesity.
Research!America board member Mark McClellan, M.D., Ph.D., director, Duke-Robert J. Margolis MD Center for Health Policy, Duke University, was quoted in a STAT news article about the cost of a new gene therapy drug.
An op-ed in The Hill penned by Research!America board member Susan Dentzer, president and CEO, Network for Excellence in Health Innovation (NEHI), and Tom Hubbard, vice president of policy research, NEHI, underscored the need to remove barriers for high-cost cancer drugs.